# Disclosing Dementia Risk Based on Plasma Phosphorylated Tau

> **NCT05377060** · NA · COMPLETED · sponsor: **Vanderbilt University Medical Center** · enrollment: 28 (actual)

## Conditions studied

- Alzheimer Disease
- Mild Cognitive Impairment

## Interventions

- **BEHAVIORAL:** Plasma p-tau risk disclosure
- **BEHAVIORAL:** Standard risk disclosure

## Key facts

- **NCT ID:** NCT05377060
- **Lead sponsor:** Vanderbilt University Medical Center
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2022-09-01
- **Primary completion:** 2025-06-01
- **Final completion:** 2025-06-01
- **Target enrollment:** 28 (ACTUAL)
- **Last updated:** 2025-06-29


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05377060

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05377060, "Disclosing Dementia Risk Based on Plasma Phosphorylated Tau". Retrieved via AI Analytics 2026-07-19 from https://api.ai-analytics.org/clinical/NCT05377060. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*